Global Pharmacovigilance (PV) Outsourcing Market Growth (Status and Outlook) 2023-2029

Global Pharmacovigilance (PV) Outsourcing Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Pharmacovigilance (PV) Outsourcing Industry Forecast” looks at past sales and reviews total world Pharmacovigilance (PV) Outsourcing sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmacovigilance (PV) Outsourcing sales for 2023 through 2029. With Pharmacovigilance (PV) Outsourcing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacovigilance (PV) Outsourcing industry.

This Insight Report provides a comprehensive analysis of the global Pharmacovigilance (PV) Outsourcing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmacovigilance (PV) Outsourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacovigilance (PV) Outsourcing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacovigilance (PV) Outsourcing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacovigilance (PV) Outsourcing.

The global Pharmacovigilance (PV) Outsourcing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Pharmacovigilance (PV) Outsourcing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pharmacovigilance (PV) Outsourcing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pharmacovigilance (PV) Outsourcing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pharmacovigilance (PV) Outsourcing players cover Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacovigilance (PV) Outsourcing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)

Segmentation by application
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen

Please note: The report will take approximately 2 business days to prepare and deliver.